Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Weider's Schiff Move Free FY 2000 Sales Jump 55% To $110 Mil.

This article was originally published in The Tan Sheet

Executive Summary

Schiff Move Free glucosamine/chondroitin sales spiked 55% to approximately $110 mil. for the fiscal year ended May 31, Weider President and CEO Bruce Wood told analysts during a conference call Aug. 18.
Advertisement

Related Content

Numico Consolidation Of Rexall, GNC Operations To Save $36 Mil.
Numico Consolidation Of Rexall, GNC Operations To Save $36 Mil.
Numico Consolidation Of Rexall, GNC Operations To Save $36 Mil.
Flexagen Joint Care "From The Makers of Advil " Hitting Shelves Now
Flexagen Joint Care "From The Makers of Advil " Hitting Shelves Now
Royal Numico/Rexall Sundown Eyes Private Label As Key Growth Area

Topics

Advertisement
UsernamePublicRestriction

Register

PS091603

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel